On the evening of February 6, 2026, Zhejiang Tianyuan Biotechnology Co., Ltd. grandly held its 2025 Annual Gala, themed "Soaring on the Wind, Rising into the Future," at the Hantang Zhizun Hotel in Ninghai. The company's management and all employees gathered together to look back on their journey of hard work and jointly chart the blueprint for development in a warm and festive atmosphere.

      At the start of the gala, General Manager Jiao Mingming outlined the development blueprint for 2026. He stated that Tianyuan Biotechnology will continue to deepen its work in the cell and gene technology fields, accelerate the industrialization of core technologies, and provide customers with higher-quality products and services. Chairman Huang Bisheng then delivered a speech, expressing gratitude to all employees for their hard work over the past year and offering the vision: "making the impossible possible, turning the possible into value, and turning value into universal benefit," calling on everyone to continue forging ahead with courage and determination on the new journey. Chairman Huang's sincere and heartfelt speech won a thunderous round of applause.

      During the banquet, a spectacular audio-visual feast was staged. Setting aside the rigor of their work, Tianyuan Biotechnology's employees showed another side of their multifaceted talents. The opening dance "Hearts in Tune, Hands Joined" was full of vitality, showcasing the team's energy and cohesion; the duet "For Whom" was deeply moving, expressing sincere affection for the company's development; the poetry recitation accompanied by a guqin performance of "Wild Geese Alighting on the Sands" carried an elegant classical charm, highlighting Tianyuan Biotechnology's profound cultural heritage; the Malay song "Gemilang" performed by Dr. Chen Junjie and "Farewell My Concubine" presented by Manager He Jianbin showcased the artistic charm of different styles; the chorus "Tomorrow Will Be Better" by all members of the cell laboratory team brought the atmosphere to a warm climax; and the dance "GG Bond" with its adorable costumes and quirky moves had the whole audience laughing continuously.

      The gala also featured multiple interactive games and lucky draw segments. Fun games such as "Musical Chairs" and "Smash the Cherry Tomatoes" allowed everyone to relax and unwind amid laughter; the successive announcement of the Lucky Prize, Third Prize, Second Prize, and First Prize pushed the atmosphere to its peak.

      With the host's closing remarks, Tianyuan Biotechnology's 2025 Annual Gala came to a successful conclusion. This was not merely a gathering to celebrate victories, but also a rally to unite hearts and boost morale. It allowed all employees of Tianyuan Biotechnology to enhance mutual understanding and trust in a relaxed and joyful atmosphere, and further strengthened their determination to contribute to the company's development.

      Standing at the new starting point of 2026, all employees of Tianyuan Biotechnology will, with greater enthusiasm and higher morale, join hands to advance and scale new heights, striving to realize the grand vision of "Gathering the Essence of Science, Safeguarding Human Health"!

      Founded in 2017, Zhejiang Tianyuan Biotechnology Co., Ltd. is a national high-tech enterprise dedicated to the integrated development of cell R&D, production, operations, and services. It holds valuable resource banks including an HLA umbilical cord matching bank, an iPS seed cell bank, and a tumor cell bank, and serves as a formulating unit for the group standard on immune function assessment methods under the National Health Commission. The company has jointly established a Metabolic and Immune Monitoring Joint Laboratory with the Institute of Science and Technology of the National Health Commission, and also serves as the Ningbo Storage Center of the National Stem Cell Translational Resource Bank and the Achievement Translation Center of the Institute of Science and Technology of the National Health Commission, among other important research and service platforms.